Concepedia

Phase Ii Study of First-Line Mfolfox Plus Cetuximab (C) for 8 Cycles Followed By Mfolfox Plus C or Single Agent (S/A) C As Maintenance Therapy in Patients (P) with Metastatic Colorectal Cancer (Mcrc): the Macro-2 Trial (Spanish Cooperative Group for the Treatment of Digestive Tumors [Ttd])

Pilar Alfonso, Manuel Benavides, A. Ruiz, Carmen Guillén‐Ponce, María José Safont, Julia Alcaide, A. Gómez, José Luís Manzano, Miguel Méndez Ureña, Fernando Rivera,

Annals of Oncology · 2014 · 18 citations · 0 references

Open access

Concepts

MedicineOncologyPharmacotherapyCancer PharmacologyChemotherapyGastrointestinal OncologyColorectal CancerCombination Cancer TherapyCombination ChemotherapyMalignant NeoplasmsMetastatic Disease TreatmentMetastatic Gastrointestinal CancerCetuximab TherapyColorectal Liver MetastasisMaintenance Therapy TrialsPhase Ii InvestigationStudy Phase